TargetRho-associated protein kinase 2(Homo sapiens (Human))
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataKi: 0.200nMAssay Description:Inhibition of ROCK2 (unknown origin) using RSK2 peptide (KKRNRTLTK) as substrate after 180 mins by luminescent kinase assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataKi: 0.400nMAssay Description:Inhibition of ROCK2 (unknown origin) using RSK2 peptide (KKRNRTLTK) as substrate after 180 mins by luminescent kinase assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataKi: 0.400nMAssay Description:Inhibition of ROCK2 (unknown origin) using RSK2 peptide (KKRNRTLTK) as substrate after 180 mins by luminescent kinase assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataKi: 0.400nMAssay Description:Inhibition of ROCK2 (unknown origin) using RSK2 peptide (KKRNRTLTK) as substrate after 180 mins by luminescent kinase assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataKi: 0.600nMAssay Description:Inhibition of ROCK2 (unknown origin) using RSK2 peptide (KKRNRTLTK) as substrate after 180 mins by luminescent kinase assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataKi: 0.700nMAssay Description:Inhibition of ROCK2 (unknown origin) using RSK2 peptide (KKRNRTLTK) as substrate after 180 mins by luminescent kinase assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataKi: 0.700nMAssay Description:Inhibition of ROCK2 (unknown origin) using RSK2 peptide (KKRNRTLTK) as substrate after 180 mins by luminescent kinase assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataKi: 0.800nMAssay Description:Inhibition of ROCK2 (unknown origin) using RSK2 peptide (KKRNRTLTK) as substrate after 180 mins by luminescent kinase assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataKi: 0.800nMAssay Description:Inhibition of ROCK2 (unknown origin) using RSK2 peptide (KKRNRTLTK) as substrate after 180 mins by luminescent kinase assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataKi: 0.800nMAssay Description:Inhibition of ROCK2 (unknown origin) using RSK2 peptide (KKRNRTLTK) as substrate after 180 mins by luminescent kinase assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataKi: 0.900nMAssay Description:Inhibition of ROCK2 (unknown origin) using RSK2 peptide (KKRNRTLTK) as substrate after 180 mins by luminescent kinase assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataKi: 0.900nMAssay Description:Inhibition of ROCK2 (unknown origin) using RSK2 peptide (KKRNRTLTK) as substrate after 180 mins by luminescent kinase assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataKi: 1nMAssay Description:Inhibition of ROCK2 (unknown origin) using RSK2 peptide (KKRNRTLTK) as substrate after 180 mins by luminescent kinase assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataKi: 1nMAssay Description:Inhibition of ROCK2 (unknown origin) using RSK2 peptide (KKRNRTLTK) as substrate after 180 mins by luminescent kinase assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataKi: 1nMAssay Description:All compounds were initially prepared as 10 mM stocks in anhydrous dimethylsulfoxide (DMSO). A 20 μl aliquot of the 10 mM solutions was transfer...More data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataKi: 1nMAssay Description:Inhibition of ROCK2 (unknown origin) using RSK2 peptide (KKRNRTLTK) as substrate after 180 mins by luminescent kinase assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataKi: 1nMAssay Description:Inhibition of ROCK2 (unknown origin) using RSK2 peptide (KKRNRTLTK) as substrate after 180 mins by luminescent kinase assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataKi: 1nMAssay Description:Inhibition of ROCK2 (unknown origin) using RSK2 peptide (KKRNRTLTK) as substrate after 180 mins by luminescent kinase assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataKi: 1nMAssay Description:Inhibition of ROCK2 (unknown origin) using RSK2 peptide (KKRNRTLTK) as substrate after 180 mins by luminescent kinase assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataKi: 1nMAssay Description:Inhibition of ROCK2 (unknown origin) using RSK2 peptide (KKRNRTLTK) as substrate after 180 mins by luminescent kinase assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataKi: 1.20nMAssay Description:Inhibition of ROCK2 (unknown origin) using RSK2 peptide (KKRNRTLTK) as substrate after 180 mins by luminescent kinase assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataKi: 1.30nMAssay Description:Inhibition of ROCK2 (unknown origin) using RSK2 peptide (KKRNRTLTK) as substrate after 180 mins by luminescent kinase assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataKi: 1.30nMAssay Description:Inhibition of ROCK2 (unknown origin) using RSK2 peptide (KKRNRTLTK) as substrate after 180 mins by luminescent kinase assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataKi: 1.30nMAssay Description:Inhibition of ROCK2 (unknown origin) using RSK2 peptide (KKRNRTLTK) as substrate after 180 mins by luminescent kinase assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataKi: 1.5nMAssay Description:Inhibition of ROCK2 (unknown origin) using RSK2 peptide (KKRNRTLTK) as substrate after 180 mins by luminescent kinase assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataKi: 1.5nMAssay Description:Inhibition of ROCK2 (unknown origin) using RSK2 peptide (KKRNRTLTK) as substrate after 180 mins by luminescent kinase assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataKi: 1.60nMAssay Description:Inhibition of ROCK2 (unknown origin) using RSK2 peptide (KKRNRTLTK) as substrate after 180 mins by luminescent kinase assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataKi: 1.70nMAssay Description:Inhibition of ROCK2 (unknown origin) using RSK2 peptide (KKRNRTLTK) as substrate after 180 mins by luminescent kinase assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataKi: 1.80nMAssay Description:Inhibition of ROCK2 (unknown origin) using RSK2 peptide (KKRNRTLTK) as substrate after 180 mins by luminescent kinase assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataKi: 1.80nMAssay Description:Inhibition of ROCK2 (unknown origin) using RSK2 peptide (KKRNRTLTK) as substrate after 180 mins by luminescent kinase assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataKi: 2nMAssay Description:Inhibition of ROCK2 (unknown origin) using RSK2 peptide (KKRNRTLTK) as substrate after 180 mins by luminescent kinase assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataKi: 2nMAssay Description:Inhibition of ROCK2 (unknown origin) using RSK2 peptide (KKRNRTLTK) as substrate after 180 mins by luminescent kinase assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataKi: 2nMAssay Description:Inhibition of ROCK2 (unknown origin) using RSK2 peptide (KKRNRTLTK) as substrate after 180 mins by luminescent kinase assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataKi: 2.20nMAssay Description:Inhibition of ROCK2 (unknown origin) using RSK2 peptide (KKRNRTLTK) as substrate after 180 mins by luminescent kinase assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataKi: 2.30nMAssay Description:Inhibition of ROCK2 (unknown origin) using RSK2 peptide (KKRNRTLTK) as substrate after 180 mins by luminescent kinase assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataKi: 2.70nMAssay Description:Inhibition of ROCK2 (unknown origin) using RSK2 peptide (KKRNRTLTK) as substrate after 180 mins by luminescent kinase assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataKi: 3nMAssay Description:Inhibition of ROCK2 (unknown origin) using RSK2 peptide (KKRNRTLTK) as substrate after 180 mins by luminescent kinase assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataKi: 3.20nMAssay Description:Inhibition of ROCK2 (unknown origin) using RSK2 peptide (KKRNRTLTK) as substrate after 180 mins by luminescent kinase assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataKi: 3.30nMAssay Description:Inhibition of ROCK2 (unknown origin) using RSK2 peptide (KKRNRTLTK) as substrate after 180 mins by luminescent kinase assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataKi: 4.20nMAssay Description:Inhibition of ROCK2 (unknown origin) using RSK2 peptide (KKRNRTLTK) as substrate after 180 mins by luminescent kinase assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataKi: 4.80nMAssay Description:Inhibition of ROCK2 (unknown origin) using RSK2 peptide (KKRNRTLTK) as substrate after 180 mins by luminescent kinase assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataKi: 5.5nMAssay Description:Inhibition of ROCK2 (unknown origin) using RSK2 peptide (KKRNRTLTK) as substrate after 180 mins by luminescent kinase assayMore data for this Ligand-Target Pair
Affinity DataKi: 6nMAssay Description:Compounds were prepared in the exact same manner as described in the ROCK Kinase Assay with the exception to the substrate and enzyme. The JAK 2× sub...More data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataKi: 6.80nMAssay Description:Inhibition of ROCK2 (unknown origin) using RSK2 peptide (KKRNRTLTK) as substrate after 180 mins by luminescent kinase assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataKi: 10nMAssay Description:Inhibition of ROCK2 (unknown origin) using RSK2 peptide (KKRNRTLTK) as substrate after 180 mins by luminescent kinase assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataKi: 16nMAssay Description:Inhibition of ROCK2 (unknown origin) using RSK2 peptide (KKRNRTLTK) as substrate after 180 mins by luminescent kinase assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataKi: 22nMAssay Description:Inhibition of ROCK2 (unknown origin) using RSK2 peptide (KKRNRTLTK) as substrate after 180 mins by luminescent kinase assayMore data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataKi: 42nMAssay Description:Inhibition of ROCK2 (unknown origin) using RSK2 peptide (KKRNRTLTK) as substrate after 180 mins by luminescent kinase assayMore data for this Ligand-Target Pair
Affinity DataKi: 211nMAssay Description:Compounds were prepared in the exact same manner as described in the ROCK Kinase Assay with the exception to the substrate and enzyme. The JAK 2× sub...More data for this Ligand-Target Pair
TargetRho-associated protein kinase 2(Homo sapiens (Human))
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Aerie Pharmaceuticals, Inc.
Curated by ChEMBL
Affinity DataKi: 275nMAssay Description:Inhibition of ROCK2 (unknown origin) using RSK2 peptide (KKRNRTLTK) as substrate after 180 mins by luminescent kinase assayMore data for this Ligand-Target Pair